FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Expands AI Capabilities and Completes Data Platform Consolidation
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Expands Market Access, Authorizes New ENDS Products
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
- FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
- FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List
- FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
- FDA Announces Major Steps to Implement Real-Time Clinical Trials
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
- CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices
- FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development
- FDA Takes Step Forward on Testosterone Therapy for Men
- FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results